Epstein-Barr virus nuclear antigen 3C is a powerful represser of transcription when tethered to DNA

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2481-2489

  Bain, Mark ^a   Watson, Roger J ^a   Farrell, Paul J ^a   Allday, Martin J ^a,b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CELL NUCLEUS ANTIGEN; CHLORAMPHENICOL ACETYLTRANSFERASE; DNA; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; REPRESSOR PROTEIN; VIRUS ANTIGEN;

ANIMAL CELL; ARTICLE; DNA BINDING; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; TRANSCRIPTION REGULATION;

3T3 CELLS; ANIMALS; ANTIGENS, VIRAL; B-LYMPHOCYTES; BINDING SITES; CELL TRANSFORMATION, VIRAL; DNA; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; MICE; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029960796     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2481-2489.1996     Document Type: Article

References (53)

1. Allday, M. J., D. H. Crawford, and B. E. Griffin. 1988 Prediction and demonstration of a novel Epstein-Barr virus nuclear antigen. Nucleic Acids Res. 16:4353-4367.
2. Allday, M. J., D. H. Crawford, and J. A. Thomas. 1993. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression or the EBV latent membrane protein and an activated phenotype in Raji cells. J. Gen. Virol 74:361-369.
3. 1-arrested cells. J. Virol. 68:3491-3498.
4. Austin, R. J., and M. D. Biggin. 1995 A domain of the even-skipped protein represses transcription by preventing TFIID binding to a promoter repression by cooperative blocking. Mol. Cell. Biol. 15:4683-4693.
5. Bahnsack, J. F., and N. R. Cooper. 1988. CR2 ligands modulate human B cell activation. J. Immunol. 141:2569-2576.
6. Bremner, R., B. L. Cohen, M. Sopta, P. A. Hamel, C. J. Ingles, B. L. Gallie, and R. A. Philips. 1995. Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol. Cell. Biol. 15:3256-3265.
7. Caswell, R., C. Hagemeier, C.-J. Chiou, G. Hayward, T. Kouzarides, and J. Sinclair. 1993. The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation. J Gen. Virol. 74:2691-2698.
8. Cowell, I. G. 1994. Repression versus activation in the control of gene transcription. Trends Biochem. Sci. 19:38-42.
9. Cowell, I. G., and H. C. Hurst. 1994. Transcriptional repression by the human bZIP factor E4BP4. definition of a minimal repression domain. Nucleic Acids Res. 22:59-65.
10. Dou, S., X. Zeng, P. Cortes, H. Erdjument-Bromage, P. Tempst, T. Honjo, and L. D. Vales. 1994. The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor. Mol. Cell. Biol. 14:3310-3319.
11. Gill, G., and M. Ptashne. 1988. Negative effect of the transcriptional activator GAL4. Nature (London) 334:721-724.
12. Graham, F. L., and A. J. Van Der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
13. Grossman, S. R., E. Johannsen, X. Tong, R. Yalamanchill, and E. Kieff. 1994. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the JK recombination signal binding protein Proc. Natl. Acad Sci USA 91:7568-7572.
14. Hagemeier, C., A. J. Bannister, A. Cook, and T. Kouzarides, 1993. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc. Natl. Acad. Sci. USA 90:1580-1584.
15. Han, K., and J. L. Manley. 1993. Transcriptional repression by the Drosophila Even-skipped protein: definition of a minimal repression domain Genes Dev. 7:491-503.
16. Han, K., and J. L. Manley. 1993. Functional domains of the Drosophila Engrailed protein. EMBO J. 12:2723-2733.
17. Henkel, T., P. D. Ling, S. D. Hayward, and M. G. Peterson. 1994. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein Jκ. Science 265:92-95.
18. Hsieh, J. J.-D., and S. D. Hayward, 1995 Masking of the CBF1RBP Jκ transcriptional repression domain by Epstein-Barr virus EBNA2 Science 268:560-563.
19. Kaelin, W. G., Jr., W. Krek, W. R. Sellers, J. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, P. J. Farnham, M. A. Blanar, D. M. Livingston, and E. Flemington. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties Cell 70:351-364.
20. Kallin, B., J. Dillner, I. Ernberg, B. Ehlin-Henriksson, A. Rosen, W. Henle, G. Henle, and G. Klein. 1986. Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells. Proc. Natl Acad Sci. USA 83:1499-1503.
21. Lam, E. W.-F., and R. J. Watson. 1993. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J 12:2705-2713.
22. Lehming, N., D. Thanos, J. M. Brickman, J. Ma, T. Maniatis, and M. Ptashne. 1994 An HMG-like protein that can switch a transcriptional activator to a repressor. Nature (London) 371:175-179.
23. Le Roux, A., B. Kerdiles, D. Walls, J.-F. Dedieu, and M. Perricaudet. 1994. The Epstein-Barr virus determined nuclear antigens EBNA-3A. -3B, and -3C repress EBNA2-mediated transactivation of the viral terminal protein 1 gene promoter. Virology 205:596-602.
24. Levine, M., and J. L. Manley. 1989. Transcriptional repression of eukaryotic promoters. Cell 59:405-408.
25. Licht, J. D., W. Hanna-Rose, J. C. Reddy, M. A. English, M. Ro, M. Grossel, R. Shaknovich, and U. Hansen. 1994. Mapping and mutagenesis of the amino-terminal repression domain of the Drosophila Kruppel protein. Mol Cell Biol. 14:4057-4066.
26. Licht, J. D., M. Ro, M. A. English, M. Grossel, and U. Hansen. 1993. Selective repression of transcriptional activators at a distance by The Dro-sophila Kruppel protein Proc. Natl. Acad. Sci. USA 90:11361-11365.
27. Lieberman, P. M., and A. J. Berk. 1991. The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein:protein interaction. Genes Dev. 5:2441-2454.
28. Liebowitz, D., and E. Kieff. 1993. Epstein-Barr virus, p. 107-172. In B. Roizman, R. J. Whitley, and C Lopez (ed.), The human herpesviruses. Raven Press, New York.
29. Lillie, J. W., and M. R. Green. 1989. Transcription activation by the adenovirus E1a protein. Nature (London) 338:39-44.
30. Lin, A., J. Frost, T. Deng, T. Smeal, N. Al-Alawi, U. Kikkawa, T. Hunter, D. Brenner, and M. Karin. 1992. Casein kinase II is a negative regulator of c-Jun binding and AP-1 activity. Cell 70:777-789.
31. Ling, P. D., D. R. Rawlins, and S. D. Hayward. 1993. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc. Natl. Acad Sci. USA 90:9237-9241.
32. Luckow, B., and G. Schutz. 1987 CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:5490
33. Madden, S. L., D. M. Cook, J. F. Morris, A. Gashler, V. P. Sukbatme, and F. J. Rauscher III. 1991. Transcriptional repression mediated by WT1 Wilms tumor gene product. Science 253:1550-1553.
34. Marshall, D., and C. Sample. 1995. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. J. Virol. 69:3624-3630.
35. Miller, J. H. 1972. Experiments in molecular genetics, p. 352-355. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
36. Pengue, G., V. Calabro, P. C. Bartoli, A. Pagliuca, and L. Lania. 1994. Repression of transcriptional activity at a distance by the evolutionarily conserved KRAB domain present in a subfamily of zinc finger proteins. Nucleic Acids Res. 22:2908-2914.
37. Petti, L., J. Sample, F. Wang, and E. Kieff. 1988. A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes. J. Virol. 62:1330-1338.
38. Renkawitz, R. 1990 Transcriptional repression in eukaryotes. Trends Genet. 6:192-197.
39. Robertson, E. S., S. Grossman, E. Johannsen, C. Miller, J. Lin, B. Tomkinson, and E. Kieff. 1995. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein Jκ. J. Virol. 69:3108-3116.
40. Rooney, C. M., D. T. Rowe, T. Ragot, and P. J. Farrell. 1989. The spliced BZLF1 gene of Epstein Barr virus (EBV) transactivates an early EBV pro-moter and induces the virus productive cycle. J. Virol. 63:3109-3116.
41. Sample, C., and B. Parker. 1994. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins. Virology 205:534-539.
42. Shi, Y., E. Seto, L.-S. Chang, and T. Shenk. 1991. Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein. Cell 67:377-388.
43. Sleigh, M. J. 1986. A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eukaryotic cells. Anal. Biochem. 156:251-256.
44. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione-S-transferase. Gene 67:31-40.
45. Tomkinson, B., E. Robertson, and E. Kieff. 1993. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol. 67:2014-2025.
46. Trautwein, C., C. Caelles, P. van der Geer, T. Hunter, M. Karin, and M. Chojkier. 1993. Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature (London) 364:544-547.
47. Um, M., C. Li, and J. L. Manley. 1995. The transcriptional repressor Even-skipped interacts directly with TATA-binding protein. Mol. Cell. Biol 15:5007-5016.
48. Ursini, M. V., T. Lettieri, M. Braddock, and G. Martini. 1993. Enhanced activity of human G6PD promoter transfected in HeLa cells producing high levels of HTV-1 Tat. Virology 196:338-343.
49. Wang, F., C. Gregory, C. Sample, M. Rowe, D. Liebowitz, R. Murray, A. Rickinson, and E. Kieff. 1990. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64:2309-2318.
50. Watson, R. J., C. Robinson, and E. W.-F. Lam. 1993. Transcription regulation by murine B-myb is distinct from that by c-myb. Nucleic Acids Res. 21:267-272.
51. G is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator. Cell 52:169-178.
52. Yeung, K. C., J. A. Inostroza, F. H. Mermelstein, C. Kannabiran, and D. Reinberg. 1994. Structure-function analysis of the TBP-binding protein Dr1 reveals a mechanism for repression of class I gene transcription Genes Dev. 8:2097-2109.
53. Zhao, B., D. R. Marshall, and C. E. Sample. Personal communication.